Genediva

Genediva, one of the largest IVF enterprises in China, through continuous independent R & D, product cooperation and license, has built a product portfolio covering the entire life cycle of IVF, including drugs, IVF laboratory information systems, equipment, and various consumables. Genediva originates from GenSci Pharmaceutical's Women's Health BU. Genediva, a wholly-owned subsidiary established by GenSci Pharmaceutical in 2023, focuses on women's health businesses. It operates with two core business units: assisted reproduction and women's health. The company aims to create a diversified product portfolio covering the entire lifecycle of women, with a comprehensive layout encompassing full-stack solutions for infertility, as well as gynecology-related areas such as menopause, gynecological infections, gynecological devices, gynecological tumors, pelvic floor health, and gynecological consumer products. It offers a women's health product matrix that combines "serious medical care and consumer healthcare" approaches.